
Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.
TB-500 research overviewTB-500 is a synthetic research peptide corresponding to a defined region of the naturally occurring protein thymosin β4. It is referenced in in-vitro laboratory literature primarily in the context of peptide characterisation and cellular actin-binding studies.
Our TB-500 is manufactured to strict laboratory standards and independently third-party tested for identity and purity, providing well-documented material for laboratory workflows.
TB-500 is referenced in laboratory literature in fields including:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every batch of TB-500 supplied by NXT GEN RESEARCH is independently third-party tested for identity and purity, giving researchers consistent, well-documented material for their laboratory workflow.
Lyophilised material: -20 °C. In solution: 2–8 °C; laboratory practice commonly references a working life of up to 28 days from first entry when stored correctly.
This product is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Copper tripeptide-1 for in-vitro biochemical characterisation.

Mitochondrial-derived peptide supplied for in-vitro laboratory research.

Multi-peptide research blend (GHK-Cu 50 mg · KPV 10 mg · BPC-157 10 mg · TB-500 10 mg) supplied for in-vitro research.

I am over 18 years of age. I am a professional or student researcher.
Research grade compounds · Not for human or animal consumption